palifermin (Kepivance)

Tradename: Kepivance Indications: - prevention of oral mucositis in selected patients preparing for bone marrow transplantation Mechanism of action: - keratinocyte growth factor Notes: Manufacturer: Amgen

General

pharmaceutical growth factor fibroblast growth factor 7; FGF-7; heparin-binding growth factor 7; HBGF-7; keratinocyte growth factor (FGF7 KGF)

References

Prescriber's Letter 12(2): 2005 New Drugs Approved by the FDA in 2004 Detail-Document#: 210216 (subscription needed) http://www.prescribersletter.com